# MK0524 Asthma POC Study (0524-008)(COMPLETED)

> **NCT00783601** · PHASE2 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 130 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Comparator: MK0524 + placebo
- **DRUG:** Comparator: MK0524 + montelukast
- **DRUG:** Comparator: placebo + montelukast
- **DRUG:** Comparator: Placebo

## Key facts

- **NCT ID:** NCT00783601
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** 2005-05
- **Final completion:** 2005-05
- **Target enrollment:** 130 (ACTUAL)
- **Last updated:** 2015-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00783601

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00783601, "MK0524 Asthma POC Study (0524-008)(COMPLETED)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00783601. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*